Security key
69012T305
Outlook Therapeutics, Inc. - Common Stock, $0.01 par value per share (OTLK)
CUSIP: 69012T305
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Stock, $0.01 par value per share
- Total 13F shares
- 4,545,632
- Total 13F value
- $8,587,260
- Share change
- -3,423,426
- Put/Call ratio
- 0.92%
- SEC-reported price per share
- $1.89
- Number of holders
- 60
- Value change
- -$17,551,788
- Number of buys
- 36
- Number of sells
- 30
- Shares outstanding
- 243,388,958
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
60
Top holders
10
OTLK full security history
Ownership snapshot
Full 13F holder table
Outlook Therapeutics, Inc. SEC filings
Outlook Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of OTLK - Outlook Therapeutics, Inc. - Common Stock, $0.01 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
TANG CAPITAL PARTNERS LP
Disclosed value leader
Arun Kumar Pillai
Comparable rows
1/15
Latest evidence
31 Dec 2024
13D/G
3/4/5
13F
Lead comparable stake: 6.4%
14 rows are not safely comparable across share classes.
13D/G row: TANG CAPITAL PARTNERS LP
Showing 1-6 of 15 holder rows.
Quick read
TANG CAPITAL PARTNERS LP leads the comparable SEC ownership view at 6.4%.
1 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens TANG CAPITAL PARTNERS LP's linked filing trail.
Comparable ownership
Top 1
TANG CAPITAL PARTNERS LP
6.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| TANG CAPITAL PARTNERS LP |
13D/G
TANG CAPITAL MANAGEMENT, LLC
|
6.4%
Reported 13D/G
· 31 Dec 2024
|
$2,624,703
1,682,502 shares
|
$0 | 31 Dec 2024 |
| Arun Kumar Pillai |
3/4/5
Director, 10%+ Owner
|
—
denominator unverified
|
$26,085,170
22,982,529 shares
|
— | 01 Feb 2022 |
| Tenshi Healthcare Pte. Ltd. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$26,085,170
22,982,529 shares
|
— | 21 Apr 2022 |
| Syntone Ventures LLC |
3/4/5
10%+ Owner
|
—
mixed-class rows
|
$716,284
2,776,867 shares
mixed-class rows
|
— | 15 Apr 2024 |
| TANG CAPITAL MANAGEMENT LLC |
13F
Company
|
—
denominator unverified
|
$8,328,050
1,559,560 shares
|
— | 30 Sep 2024 |
| GREAT POINT PARTNERS LLC |
13F
Company
|
—
denominator unverified
|
$6,904,770
1,293,028 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
60
Shares
4,545,632
Rows available
60
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
65
Q4 2024 holders
60
Holder diff
-5
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|